KYNB

Conviction 44HealthcareScan · Fri, Jun 26, 2026

KYNB$7.33+5.55%

ResistanceSupportVol 14Insider buy

Vol MA14 78.8K

Mar 27Apr 15May 4May 20Jun 9Jun 26

KYNTRA BIO, INC.PHARMACEUTICAL PREPARATIONSwww.kyntrabio.com ↗

Price7.33

Change+5.55%

Gap+2.52%

Rel volume12.92×

Avg volume57.39K

Avg $ vol410.31K

SMA 206.87

SMA 506.98

SMA 200—

Price vs 50+5.01%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 6.50

RSI (14)63

MACD hist0.05

MACD crossbull · 9d

Stoch %K / %D55 / 37

ADX (14)24

+DI / −DI30 / 11

RSI divergence—

MACD divergence—

ATR %+4.11%

ADR %4.28%

52w high9.50

52w low6.46

From 52w high-22.89%

Above 52w low+13.39%

New 52w highNo

SqueezeOn · 44d

Bollinger width9.18%

%B1.23

Donchian pos55.36%

Donchian high7.95

Donchian low6.55

AVWAP (52w high)7.43

vs AVWAP high-1.35%

AVWAP (52w low)7.14

vs AVWAP low+2.62%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d12.92×

Avg vol (14d)78.8K

Avg vol (20d)57.39K

Avg $ vol (20d)410.31K

Market cap—

RS 3m (vs SPY)-9.59%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank79.1

1 week+9.33%

1 month+4.49%

3 months+12.00%

6 months—

1 year—

YTD-22.89%

P/E0.16

P/B-0.66

P/S4.52

P/FCF-6.05

EPS45.37

Div yield—

ROE-418.81%

ROA167.34%

Debt/Eq-1.71

Current3.61

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-78.26%

EPS growth485.57%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value67.11M

Revenue3.74M

Net income-15.2M

Gross profit—

Free cash flow-4.81M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out4.05M

Employees34

ListedFri, Nov 14, 2014

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction44 / 100

Pattern quality—

Tech rank79.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.63

Support6.60

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KYNB

All disclosures →

No recent disclosed trades by Congress in KYNB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KYNB · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
DeLucia David Chief Financial Officer · Common Stock · 2026-06-06	Tax	52	$349	2026-06-06	2026-06-09
Wettig Thane CEO · Common Stock · 2026-06-06	Tax	198	$1K	2026-06-06	2026-06-09
Wettig Thane CEO · Common Stock · 2026-06-06	Other	—	—	2026-06-06	2026-06-09
Wettig Thane CEO · Common Stock · 2026-05-14	Buy	2.8K	$20K	2026-05-14	2026-05-19
Wettig Thane CEO · Common Stock · 2026-05-14	Other	—	—	2026-05-14	2026-05-19
Wettig Thane CEO · Common Stock · 2026-05-14	Other	—	—	2026-05-14	2026-05-18
Wettig Thane CEO · Common Stock · 2026-05-14	Buy	2.8K	$20K	2026-05-14	2026-05-18

SEC filings

EDGAR filings in KYNB · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.